# Charles-Edouard Bouee

> Charles-Edouard Bouee is a pre-seed investor in Munich backing Biotechnology and Natural Resources. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: Munich, Germany
- Total investments: 5
- Last investment: Oct 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/charlesedouardbouee/
- X (Twitter): https://twitter.com/cebouee
- Website: https://x.com/cebouee

Charles-Edouard Bouee is a pre-seed investor in Munich focused on Biotechnology and Natural Resources. Charles-Edouard Bouée is the CEO of Roland Berger. He is a seasoned expert in reorganization, post-merger projects and integration programs, as well as performance improvement, and specializes in disruptive innovation, new technologies and digital transformation.Charles-Edouard Bouée joined Roland Berger in 2001 as Senior Partner in the Parisoffice, where he headed the Financial Services and Energy & Utility Competence Centers. He became the Managing Partner of Roland Berger’s China office in 2006 and Head of the Asia Leadership Team in 2009.He then assumed responsibility for France, Belgium, Italy, Spain and Morocco. He has since fulfilled consulting mandates for leading international companies and organizations based in Europe, Asia and elsewhere. Charles-Edouard Bouée was appointed COO in July 2013 and elected CEO of Roland Berger in June 2014.Charles-Edouard Bouée has authored various books on modern management and China, as well as Artificial Intelligence.

## Round sizes

| Stage | Round size |
| --- | --- |
| Pre-Seed | $348k–$1M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Natural Resources | 2 | 40% |
| AgTech | 1 | 20% |
| Beauty | 1 | 20% |
| Mining | 1 | 20% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 2 | 40% |
| Seed | 1 | 20% |
| Angel | 1 | 20% |
| Series D | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| France | 1 | 20% |
| Vietnam | 1 | 20% |
| Cameroon | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Jetti Resources | Jetti makes it possible to extract copper from low-grade primary sulfides, such as chalcopyrite, the world’s most abundant copper mineral ore.Jetti’s commercially proven and proprietary catalytic technology addresses the key technical problem preventing the recovery of trillions of dollars of trapped resources. We apply our catalysts to hundredsof millions of tons of ore, and significantly increase copper yields in a cost-effective and environmentally responsible manner. | $100M | Series D | Oct 24, 2022 |  |
| PaySika | PaySika is a financial technology startup developing mobile and web-based banking solutions for French-speaking African countries. | $348K | Pre-Seed | Oct 15, 2021 |  |
| INTERSTELLAR LAB | Interstellar Lab is a biotech company founded in 2018 that develops, manufactures and operates advanced bio-farming platforms to help its customer produce the cleanest plant-based ingredients. Its bio-farming technology combines automated farms (Biopods), AI and bioscience with a unique data-driven approach. Its considerably accelerates plantgrowth while optimizing plant molecular composition. Interstellar Lab provides sustainable plant-based ingredient solutions to large health, beauty and F&B companies. Its bio-farming technology has also convinced NASA and ESA, which contracted with the company to adapt the system for space deployment. The company counts 45 engineers, scientists and researchers located between its flagship 65,000SF BioPod Facility and Plant Lab in Ivry-sur-Seine (France), its SpaceLab at NASA KSC Florida (USA) and its Business Hub in San Francisco (USA). | $1M | Pre-Seed | Dec 21, 2020 |  |
| xRapid | xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobilesolution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea. | $250K | Angel | Jun 15, 2016 |  |
| Leflair | Leflair is a premium online outlet, selling discounted merchandise.Leflair was launched in Vietnam in 2015 as the country’s first premium e-commerce website for women, men, kids, and home. They launch limited-time sales every morning with prices up to 70% off retail, making the world’s best brands accessible in Vietnam.The company'squality and authenticity are its core, which is why they only partner directly with brands, conduct the most rigorous quality control and treat every package as a present. | $750K | Seed | May 31, 2016 |  |

5 of 5 investments shown.

## Co-investors
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Africa Venture Labs](https://shizune.co/investors/profile/africa-venture-labs) — VC Fund, 1 deal together
- [AppleTree Group](https://shizune.co/investors/profile/appletree-group) — VC Fund, 1 deal together
- [BHP Ventures](https://shizune.co/investors/profile/bhp-ventures) — VC Fund, 1 deal together
- [DNS Capital](https://shizune.co/investors/profile/dns-capital) — VC Fund, 1 deal together
- [Freeport Mcmoran](https://shizune.co/investors/profile/freeport-mcmoran) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Unilever Ventures](https://shizune.co/investors/profile/unilever-ventures) — VC Fund
- [Fab Co-Creation Studio Ventures](https://shizune.co/investors/profile/fab-co-creation-studio-ventures) — VC Fund
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [Mekong Capital](https://shizune.co/investors/profile/mekong-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Touchstone Partners](https://shizune.co/investors/profile/touchstone-partners) — VC Fund

## Featured in investor lists
- [All Angel Investors in Vietnam](https://shizune.co/investors/angel-investors-vietnam)
- [All Investors in Cameroon](https://shizune.co/investors/investors-cameroon)
- [All Angel Investors in Cameroon](https://shizune.co/investors/angel-investors-cameroon)
- [Fashion Investors in Vietnam](https://shizune.co/investors/fashion-investors-vietnam)
- [Payments Angel Investors in Africa](https://shizune.co/investors/payments-angel-investors-africa)
- [Medical Angel Investors in France](https://shizune.co/investors/medical-angel-investors-france)

## FAQ

### What does Charles-Edouard Bouee invest in?

Charles-Edouard Bouee invests primarily in Biotechnology, Natural Resources and AgTech startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Charles-Edouard Bouee's check size?

Charles-Edouard Bouee typically joins rounds of $348k–$1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Charles-Edouard Bouee participates in.

### When did Charles-Edouard Bouee last invest?

The most recent investment recorded for Charles-Edouard Bouee closed in Oct 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co